A carregar...
Adalimumab in ulcerative colitis: Two cases of mucosal healing and clinical response at two years
Infliximab (IFX) is currently the only biologic therapy used in the treatment of moderate-to-severe ulcerative colitis (UC). In the years to come, more biologic therapies will have a role in the management of moderate-to-severe UC. We report on two patients with steroid-dependent UC who, due to adve...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The WJG Press and Baishideng
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2726462/ https://ncbi.nlm.nih.gov/pubmed/19673025 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.15.3814 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|